• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用动态 [F]JNJ-64413739 PET 和 MRA 驱动的图像衍生输入函数微创定量脑 P2X7R 占有率。

Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [F]JNJ-64413739 PET and MRA-driven image derived input function.

机构信息

Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Janssen Research and Development, Beerse, Belgium.

出版信息

Sci Rep. 2021 Aug 9;11(1):16172. doi: 10.1038/s41598-021-95715-y.

DOI:10.1038/s41598-021-95715-y
PMID:34373571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8352986/
Abstract

[F]JNJ-64413739 has been evaluated as PET-ligand for in vivo quantification of purinergic receptor subtype 7 receptor (P2X7R) using Logan graphical analysis with a metabolite-corrected arterial plasma input function. In the context of a P2X7R PET dose occupancy study, we evaluated a minimally invasive approach by limiting arterial sampling to baseline conditions. Meanwhile, post dose distribution volumes (V) under blocking conditions were estimated by combining baseline blood to plasma ratios and metabolite fractions with an MR angiography driven image derived input function (IDIF). Regional postdose V values were compared with corresponding V estimates using a arterial input function (AIF), in terms of absolute values, test-retest reliability and receptor occupancy. Compared to an invasive AIF approach, postdose V values and corresponding receptor occupancies showed only limited bias (Bland-Altman analysis: 0.06 ± 0.27 and 3.1% ± 6.4%) while demonstrating a high correlation (Spearman ρ = 0.78 and ρ = 0.98 respectively). In terms of test-retest reliability, regional intraclass correlation coefficients were 0.98 ± 0.02 for V compared to 0.97 ± 0.01 for V These results confirmed that a postdose IDIF, guided by MR angiography and using baseline blood and metabolite data, can be considered for accurate [F]JNJ-64413739 PET quantification in a repeated PET study design, thus avoiding multiple invasive arterial sampling and increasing dosing flexibility.

摘要

[F]JNJ-64413739 已被评估为嘌呤能受体亚型 7 受体 (P2X7R) 的 PET 配体,使用 Logan 图形分析,采用校正代谢物的动脉血浆输入函数进行体内定量。在 P2X7R PET 剂量占有率研究中,我们通过将动脉取样限制在基线条件下,评估了一种微创方法。同时,通过将基线血液与血浆比值和代谢物分数与磁共振血管造影驱动的图像衍生输入函数 (IDIF) 相结合,估算了阻断条件下的分布体积 (V)。根据绝对值、测试-重测可靠性和受体占有率,将基础状态下的 V 值与相应的 V 估计值进行了比较。与侵入性 AIF 方法相比,给药后 V 值和相应的受体占有率仅显示出有限的偏差 (Bland-Altman 分析:0.06 ± 0.27 和 3.1% ± 6.4%),同时具有很高的相关性 (Spearman ρ = 0.78 和 ρ = 0.98)。在测试-重测可靠性方面,V 的区域内组内相关系数为 0.98 ± 0.02,而 V 的区域内组内相关系数为 0.97 ± 0.01。这些结果证实,在重复 PET 研究设计中,通过磁共振血管造影引导,使用基础状态下的血液和代谢物数据,可考虑使用给药后 IDIF 进行 [F]JNJ-64413739 PET 定量,从而避免多次侵入性动脉取样,并增加给药灵活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/90602331734d/41598_2021_95715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/3f99ab02b814/41598_2021_95715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/3c8efb59a649/41598_2021_95715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/c06f4b233429/41598_2021_95715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/134932ba2074/41598_2021_95715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/36ab073397d3/41598_2021_95715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/90602331734d/41598_2021_95715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/3f99ab02b814/41598_2021_95715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/3c8efb59a649/41598_2021_95715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/c06f4b233429/41598_2021_95715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/134932ba2074/41598_2021_95715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/36ab073397d3/41598_2021_95715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af85/8352986/90602331734d/41598_2021_95715_Fig6_HTML.jpg

相似文献

1
Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [F]JNJ-64413739 PET and MRA-driven image derived input function.采用动态 [F]JNJ-64413739 PET 和 MRA 驱动的图像衍生输入函数微创定量脑 P2X7R 占有率。
Sci Rep. 2021 Aug 9;11(1):16172. doi: 10.1038/s41598-021-95715-y.
2
F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446.F-JNJ-64413739,一种新型 P2X7 离子通道 PET 配体:辐射剂量学、动力学建模、重复测量变异性和 P2X7 拮抗剂 JNJ-54175446 的占有率。
J Nucl Med. 2019 May;60(5):683-690. doi: 10.2967/jnumed.118.216747. Epub 2018 Sep 27.
3
Assessment of [F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function.通过无创自动图像衍生输入函数评估 [F]PI-2620 Tau-PET 定量。
Eur J Nucl Med Mol Imaging. 2024 Sep;51(11):3252-3266. doi: 10.1007/s00259-024-06741-7. Epub 2024 May 8.
4
Validation of a combined image derived input function and venous sampling approach for the quantification of [F]GE-179 PET binding in the brain.验证一种结合了图像衍生输入函数和静脉取样方法,用于定量测量脑内 [F]GE-179 PET 结合。
Neuroimage. 2021 Aug 15;237:118194. doi: 10.1016/j.neuroimage.2021.118194. Epub 2021 May 21.
5
Preclinical Evaluation and Quantification of F-Fluoroethyl and F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A Receptor in Rat Brain.SCH442416的F-氟乙基和F-氟丙基类似物作为大鼠脑内腺苷A受体PET成像放射性配体的临床前评估与定量分析
J Nucl Med. 2017 Mar;58(3):466-472. doi: 10.2967/jnumed.116.178103. Epub 2016 Oct 27.
6
Image Quantification for TSPO PET with a Novel Image-Derived Input Function Method.基于新型图像衍生输入函数法的TSPO PET图像定量分析
Diagnostics (Basel). 2022 May 7;12(5):1161. doi: 10.3390/diagnostics12051161.
7
Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of F-JNJ-64413739, a PET Radioligand for P2X7 Receptors.用于 P2X7 受体的 PET 放射性配体 F-JNJ-64413739 的临床前评估和非人类灵长类动物受体占有率研究。
J Nucl Med. 2019 Aug;60(8):1154-1159. doi: 10.2967/jnumed.118.212696. Epub 2019 Feb 7.
8
Towards quantitative [18F]FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic rates.实现脑[18F]FDG-PET/MRI 的定量分析:自动基于 MR 的图像衍生输入函数计算,用于非侵入性测定脑葡萄糖代谢率。
J Cereb Blood Flow Metab. 2019 Aug;39(8):1516-1530. doi: 10.1177/0271678X18776820. Epub 2018 May 23.
9
Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.一种P2X7受体选择性放射性示踪剂的临床前评估:在人P2X7受体局部过表达的大鼠模型和非人灵长类动物中的PET研究
J Nucl Med. 2016 Sep;57(9):1436-41. doi: 10.2967/jnumed.115.169995. Epub 2016 May 19.
10
Image-derived input function in dynamic human PET/CT: methodology and validation with 11C-acetate and 18F-fluorothioheptadecanoic acid in muscle and 18F-fluorodeoxyglucose in brain.动态人体 PET/CT 中的图像衍生输入函数:使用 11C-乙酸盐和 18F-氟硫辛酸在肌肉中以及 18F-氟脱氧葡萄糖在脑中进行方法学和验证。
Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1539-50. doi: 10.1007/s00259-010-1443-z. Epub 2010 May 2.

引用本文的文献

1
Triazole-Based Radioligands for PET of P2XR: Syntheses, Conformational Studies, and Preliminary Autoradiographic Evaluation of .用于P2XR正电子发射断层显像(PET)的基于三唑的放射性配体:合成、构象研究及初步放射自显影评估
ACS Omega. 2025 Aug 6;10(32):36340-36350. doi: 10.1021/acsomega.5c04531. eCollection 2025 Aug 19.
2
Radioligands Targeting the Purinergic P2X Receptors.靶向嘌呤能P2X受体的放射性配体
Cells. 2025 Jun 27;14(13):984. doi: 10.3390/cells14130984.
3
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?神经炎症的正电子发射断层显像(PET)成像:目前是否有比转运蛋白18 kDa(TSPO)更可靠的替代物?

本文引用的文献

1
The P2X receptor tracer [C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study.P2X受体示踪剂[C]SMW139作为多发性硬化症神经炎症的体内标志物:一项人体首次研究。
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):379-389. doi: 10.1007/s00259-019-04550-x. Epub 2019 Nov 8.
2
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study.TSPO 与 P2X7 作为神经炎症靶点:一项体外和体内研究。
J Nucl Med. 2020 Apr;61(4):604-607. doi: 10.2967/jnumed.119.231985. Epub 2019 Sep 27.
3
Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.
Mol Psychiatry. 2025 Jan;30(1):213-228. doi: 10.1038/s41380-024-02656-9. Epub 2024 Jul 13.
4
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine.P2X7 受体在诊断医学中的崭露头角。
Int J Mol Sci. 2023 May 30;24(11):9465. doi: 10.3390/ijms24119465.
5
Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies.用于脑 PET 研究定量分析的无创动力学建模方法。
Eur J Nucl Med Mol Imaging. 2023 May;50(6):1636-1650. doi: 10.1007/s00259-022-06057-4. Epub 2023 Jan 18.
6
Characterization of the Novel P2X7 Receptor Radioligand [H]JNJ-64413739 in Human Brain Tissue.新型 P2X7 受体放射性配体 [H]JNJ-64413739 在人脑组织中的特征描述。
ACS Chem Neurosci. 2023 Jan 4;14(1):111-118. doi: 10.1021/acschemneuro.2c00561. Epub 2022 Dec 19.
7
Increased uptake of the P2X7 receptor radiotracer F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice.根据雄性小鼠癫痫持续状态的严重程度,P2X7 受体放射性示踪剂 F-JNJ-64413739 在大脑和外周器官中的摄取增加。
Epilepsia. 2023 Feb;64(2):511-523. doi: 10.1111/epi.17484. Epub 2022 Dec 27.
淀粉样蛋白、tau 和神经炎症 PET 成像在阿尔茨海默病和轻度认知障碍中的应用。
Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14.
4
Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism.完全集成的 PET/MRI 的前景:无创性临床定量评估脑葡萄糖代谢。
J Nucl Med. 2020 Feb;61(2):276-284. doi: 10.2967/jnumed.119.229567. Epub 2019 Aug 2.
5
[C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson's disease and healthy volunteers.[C]JNJ54173717,一种新型 P2X7 受体放射性配体,作为神经炎症的标志物:在帕金森病患者和健康志愿者中的人体分布、剂量学、脑内动力学模型和 P2X7 受体定量研究。
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2051-2064. doi: 10.1007/s00259-019-04369-6. Epub 2019 Jun 26.
6
Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of F-JNJ-64413739, a PET Radioligand for P2X7 Receptors.用于 P2X7 受体的 PET 放射性配体 F-JNJ-64413739 的临床前评估和非人类灵长类动物受体占有率研究。
J Nucl Med. 2019 Aug;60(8):1154-1159. doi: 10.2967/jnumed.118.212696. Epub 2019 Feb 7.
7
P2X7 PET Radioligand F-PTTP for Differentiation of Lung Tumor from Inflammation.P2X7 PET 放射性配体 F-PTTP 可用于区分肺部肿瘤与炎症。
J Nucl Med. 2019 Jul;60(7):930-936. doi: 10.2967/jnumed.118.222547. Epub 2019 Jan 17.
8
PET Imaging of the P2X7 Ion Channel with a Novel Tracer [F]JNJ-64413739 in a Rat Model of Neuroinflammation.新型示踪剂[F]JNJ-64413739 对神经炎症大鼠模型中 P2X7 离子通道的 PET 成像研究。
Mol Imaging Biol. 2019 Oct;21(5):871-878. doi: 10.1007/s11307-018-01313-2.
9
Test-retest reliability and convergent validity of (R)-[C]PK11195 outcome measures without arterial input function.无动脉输入函数的(R)-[C]PK11195结果测量的重测信度和收敛效度。
EJNMMI Res. 2018 Nov 29;8(1):102. doi: 10.1186/s13550-018-0455-8.
10
F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446.F-JNJ-64413739,一种新型 P2X7 离子通道 PET 配体:辐射剂量学、动力学建模、重复测量变异性和 P2X7 拮抗剂 JNJ-54175446 的占有率。
J Nucl Med. 2019 May;60(5):683-690. doi: 10.2967/jnumed.118.216747. Epub 2018 Sep 27.